glp 1 and medicare coverage CMS Issues Guidance on GLP-1 Anti-Obesity Drugs GLP-1 Weight-Loss Drug Demonstration Begins

To learn more about coverage, call your provider

6.1 Expression of GLP-1 and GIP Receptors in the Brain GLP-1 receptors are expressed on neurons in most areas of the brain, including the cortex, hippocampus, and the striatum [105,106,107,108,109,110]

Selective activation of parvalbumin- or somatostatin-expressing interneurons triggers epileptic seizurelike activity in mouse medial entorhinal cortex

The authors concluded that GLP-1 receptor agonists are a safe and effective adjunct treatment for weight reduction in women with PCOS. A 2025 review of human and animal studies concluded that GLP-1 receptor agonists offer a multifaceted approach to PCOS management, with benefits across both metabolic and reproductive domains, including improvements in insulin sensitivity, weight loss, and menstrual regularity, with emerging evidence suggesting possible effects on gut microbiota composition